Dr. Andreas Boker, MD

Dr. Boker practices at Spring Street Dermatology in New York, New York.

Dr. Boker's NPI, 1306972120, was assigned on February 26, 2007. Dr. Boker graduated from Universidad La Salle School of Medicine in 1998. Dr. Boker holds New York license 262834.

Dr. Boker's primary practice is Spring Street Dermatology, at 4 W 58th St, New York, NY 10019 in New York County. The practice phone is (212) 431-4749.

Dr. Boker's primary practice is Spring Street Dermatology in New York, New York. The medical group on file is Spring Street Dermatology. Dmand AI also links Dr. Boker to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boker practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Boker's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Boker is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Boker's licenses on file in 3 states: New York, California and Connecticut.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, minor injury to a limb, psoriasis and scalp rash among the conditions Dr. Boker treats.

CMS data shows 1,734 Medicare services from Dr. Boker across 10 procedure codes in 2024, for 297 Medicare patients. Medicare paid $111,884 for them. Every service was in an office.

CMS counts 297 Medicare patients who saw Dr. Boker in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high cholesterol, and 53% have high blood pressure. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boker's median patient age at 44, with 52% women.

In 2024, Dr. Boker wrote 330 Medicare Part D claims for 139 patients. 82% of them were for generic drugs. CMS names the drug for 229 of them, across 10 drugs with 11 or more claims each, at $7,706 in total drug cost. In 2023, CMS named 190 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Boker for performance year 2024, reported individually. Dr. Boker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 362 procedures of removal of skin lesions by Dr. Boker, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Boker, published from 2009 to 2012. Dr. Boker's most frequent co-authors are Gabriela Maria Blanco, MD, David Hermogenes Ciocon, MD and Seema J. Daulat, MD.

Dmand AI links Dr. Boker to 1 clinical trial. Conditions studied include Acneiform Eruptions and Acne Vulgaris.

CMS Open Payments shows 126 general payments to Dr. Boker from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $600.

Dmand AI lists 1 award for Dr. Boker.

Dr. Boker graduated from Universidad La Salle School of Medicine in 1998. Dr. Boker is a member of AAD, American College of Mohs Surgery and ASDS.

Dr. Boker is in network with 16 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.